Wainua
Payments companies reported to CMS as associated with Wainua. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Wainua, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Wainua
These are the largest totals companies reported as associated with Wainua. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dmitry Yaranov | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $280,208.87 |
| Brent Goodman | Scottsdale, AZ | Neurology (Psychiatry & Neurology) | $195,336.11 |
| Vasvi Singh | Overland Park, KS | Cardiovascular Disease | $162,513.25 |
| Andrew Darlington | Fayetteville, GA | Advanced Heart Failure and Transplant Cardiology | $136,993.38 |
| Sabahat Bokhari | Allentown, PA | Cardiovascular Disease | $123,137.01 |
| Roxana Ghashghaei | Laguna Hills, CA | Cardiovascular Disease | $117,671.56 |
| Alejandra Gonzalez-Duarte | New York, NY | General Practice | $92,094.53 |
| Richard Wright | Santa Monica, CA | Advanced Heart Failure and Transplant Cardiology | $88,117.86 |
| Christopher Bell | Tupelo, MS | Acute Care (Nurse Practitioner) | $78,371.41 |
| Marcus Urey | San Diego, CA | Advanced Heart Failure and Transplant Cardiology | $67,982.51 |
Prescribed Wainua?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.